Status:
COMPLETED
Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Daiichi Sankyo
Conditions:
Hyperlipidemia
Dyslipidemia
Eligibility:
All Genders
18-89 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to see if combination therapy with a "statin" medication and two additional agents that work differently than "statin" medications can further lower the so-called "bad cho...
Detailed Description
Coronary heart disease (CHD) is the primary cause of morbidity and mortality in the United States. Lowering LDL cholesterol in both patients with and without CHD reduces coronary events and death. Sta...
Eligibility Criteria
Inclusion
- Diagnosis of high cholesterol being treated with a statin
- LDL cholesterol greater than 100
- Ability to swallow large tablets
Exclusion
- Diabetes
- Use of other medications to treat high cholesterol
- History of liver disease
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00249938
Start Date
March 1 2005
End Date
August 1 2006
Last Update
March 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado at Denver and Health Sciences Center
Denver, Colorado, United States, 80262